产品编号:B182695
产品规格:10mg
产品价格:面议
| 标准品编号: | B182695 |
| 名称: | N-[4-[[(5S)-5-(Benzoyloxy)-7-chloro-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]carbonyl]-3-methylphenyl]-2-methylbenzamide |
| CAS号: | 422571-07-1 |
| 分子式: | C₃₃H₂₉ClN₂O₄ |
| 外观: | 白色固体 |
| 分子量: | 553.05 |
| 溶解度: | Dichloromethane; |
| 类别: | Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: | N-​[4-​[[(5S)​-​5-​(Benzoyloxy)​-​7-​chloro-​2,​3,​4,​5-​tetrahydro-​1H-​1-​benzazepin-​1-​yl]​carbonyl]​-​3-​methylphenyl]​-​2-​methylbenzamide is an intermediate in the synthesis of (S)-(-)-Tolvaptan (T536645), which is an enantiomer of Tolvaptan. It is a selective, competitive arginine vasopressin V2 receptor antagonist used to treat hyponatremia (low blood sodium levels) associated with congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone (SIADH). |
| 文献 | |